APA

Schlütermann D., Skowron M. A., Berleth N., Böhler P., Deitersen J., Stuhldreier F., Wallot-Hieke N., Wu W., Peter C., Hoffmann M. J., Niegisch G. & Stork B. (20181105). Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. : Urologic oncology.

Chicago

Schlütermann David, Skowron Margaretha A, Berleth Niklas, Böhler Philip, Deitersen Jana, Stuhldreier Fabian, Wallot-Hieke Nora, Wu Wenxian, Peter Christoph, Hoffmann Michèle J, Niegisch Günter and Stork Björn. 20181105. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. : Urologic oncology.

Harvard

Schlütermann D., Skowron M. A., Berleth N., Böhler P., Deitersen J., Stuhldreier F., Wallot-Hieke N., Wu W., Peter C., Hoffmann M. J., Niegisch G. and Stork B. (20181105). Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. : Urologic oncology.

MLA

Schlütermann David, Skowron Margaretha A, Berleth Niklas, Böhler Philip, Deitersen Jana, Stuhldreier Fabian, Wallot-Hieke Nora, Wu Wenxian, Peter Christoph, Hoffmann Michèle J, Niegisch Günter and Stork Björn. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. : Urologic oncology. 20181105.